Jubilant Pharmova Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

403.70

427.54

47.46

40.29

1,514.70

Operating profit

5.00

2.93

-6.94

0.16

250.49

Interest

13.50

7.29

15.91

14.68

66.93

Gross profit

25.80

112.00

-7.17

95.67

205.43

EPS (Rs)

0.09

5.44

-0.53

5.46

7.20

Other income

34.30

116.36

15.68

110.19

21.87

Stock adjustment

20.90

32.72

-

-

13.49

Raw material

166.80

189.26

-

-

749.18

Power and fuel

-

-

-

-

164.68

Employee expenses

93.60

84.29

26.14

23.07

121.04

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

117.40

118.34

28.26

17.06

215.82

Provisions made

-

-

-

-

-

Depreciation

23.30

20.29

3.19

3.06

59.12

Taxation

1.00

5.08

-1.91

5.66

31.64

Net profit / loss

1.50

86.63

-8.45

86.95

114.67

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

15.90

15.93

15.93

15.93

15.93

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

1.24

0.69

-14.62

0.40

16.54

GPM (%)

5.89

20.59

-11.36

63.58

13.37

NPM (%)

0.34

15.93

-13.38

57.78

7.46